Check out the new Prime/MRx GLP-1 Strategy page

After the release of its industry-leading research on GLP-1a drugs for weight loss in July 2023, Prime Therapeutics/Magellan Rx Management (Prime/MRx) continues to shape the narrative on this dynamic trend.

We’ve compiled all of our GLP-1 resources and thought leadership onto a new GLP-1 Strategy page, including our research, podcasts, videos, recent articles and more. Our aim is to highlight our evidence-based approach to GLP-1 drugs, working with our partners to develop individualized strategies that promote clinically appropriate use and consider total cost of care, long-term value, and member health outcomes.

For more, check back for regular updates on our Prime News site.

And to get the latest news and insights from Prime/MRx, sign-up for our twice-a-month newsletter, Prime Post.

Subscribe to the Prime Post newsletter

About Prime Therapeutics + Magellan Rx

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Prime is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Magellan Rx Management LLC, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit primetherapeutics.com and magellanrx.com or follow us on X (Twitter) at @Prime_PBM and @Magellan_Rx.

Related news

Perspectives

July 25, 2024

Quarterly Drug Pipeline: July 2024

Clinical insights and competitive intelligence on anticipated drugs in development

Perspectives

July 22, 2024

Oncology Insights: 2024 ASCO Annual Meeting key findings

Findings from this year’s American Society of Clinical Oncology (ASCO) Annual Meeting will likely lead to clinical practice changes and U.S. Food and Drug Administration (FDA) drug approvals or expansions

Perspectives

July 16, 2024

LISTEN NOW: Beyond the business – Stories of corporate kindness | Pharmacy Friends Podcast

In this episode, we talk about how our employees' help goes beyond our work in health care, aiding in philanthropic efforts

View all news